Institut Paoli-Calmettes- (IPC)

corporate_fareorganization

Institut Paoli-Calmettes- (IPC)

- Funding / Projects
  (113)

113 Projects, page 1 of 23

ALTER-GREF: Randomized prospective phase II clinical trial using post-transplantation cyclophosphamide for prevention of GVHD in haploidentical and HLA 9/10 mismatched unrelated donors hematopoietic stem cell transplant
assignment_turned_inProjectPartners:HUS, Groupe Hospitalier Pitié Salpétrière, HUG, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Poitiers +10 partners
HUS,
Groupe Hospitalier Pitié Salpétrière,
HUG,
Hôpital Claude Huriez,
Centre Hospitalier Universitaire de Poitiers,
Centre Hospitalier Universitaire de Toulouse,
Centre Hospitalier Universitaire de Limoges,
Institut Paoli-Calmettes- (IPC),
CHRU MTP,
Hôpital Necker- Enfants malades,
HCL,
Institut de cancérologie Lucien Neuwirth,
CHU Nantes - Hôtel Dieu,
CHU,
Groupe Hospitalier Henri Mondor - Albert Chenevier
Funder: Institut National du Cancer Project Code: INCa-DGOS-11089
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
BACAP Project
assignment_turned_inProject2013 - 2016Partners:Assistance Publique - Hôpitaux de Marseille (AP-HM), Groupe francophone Thrombose et Cancer, Centre Hospitalier Universitaire de Toulouse, ICM-VAL D'AURELLE, Hôpital privé Jean Mermoz +7 partners
Assistance Publique - Hôpitaux de Marseille (AP-HM),
Groupe francophone Thrombose et Cancer,
Centre Hospitalier Universitaire de Toulouse,
ICM-VAL D'AURELLE,
Hôpital privé Jean Mermoz,
Registre Bourguignon des cancers digestifs,
Institut Paoli-Calmettes- (IPC),
Hôpital Beaujon,
INSERM U1027,
Hôpital de Rangueil,
Institut Gustave Roussy,
Hôpital de l'Archet
Funder: Institut National du Cancer Project Code: INCa-6294
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Randomized phase III study of gemcitabine and cisplatin (GC) versus high-dose-intensity methotrexate, vinblastine, doxorubicin and cisplatin (HD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder
assignment_turned_inProjectPartners:Centre François Baclesse, Centre Léon Bérard, Institut Bergonié, Hôpital Saint-Louis, Institut Curie +6 partners
Centre François Baclesse,
Centre Léon Bérard,
Institut Bergonié,
Hôpital Saint-Louis,
Institut Curie,
Centre Hospitalier Universitaire de Rouen,
HUS,
Institut de cancérologie Lucien Neuwirth,
Institut Paoli-Calmettes- (IPC),
Institut Claudius Regaud,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-3712
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
EPIC-2015: Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers, treated with first-line chemotherapy: a randomized phase III trial
assignment_turned_inProjectPartners:Centre Antoine Lacassagne, Centre Oscar Lambret, Institut Bergonié, INSERM U1113, Centre Georges-François Leclerc +2 partners
Centre Antoine Lacassagne,
Centre Oscar Lambret,
Institut Bergonié,
INSERM U1113,
Centre Georges-François Leclerc,
Institut Paoli-Calmettes- (IPC),
Centre Léon Bérard
Funder: Institut National du Cancer Project Code: INCa-DGOS-11170
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
PHOCEA - institut Paoli calmettes Hospital Organization and scientifiC program for Early phase trials Activity
assignment_turned_inProjectUntil 2024Partners:Institut Paoli-Calmettes- (IPC)
Institut Paoli-Calmettes- (IPC)
Funder: Institut National du Cancer Project Code: INCa-13725
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Institut Paoli-Calmettes- (IPC)

Institut Paoli-Calmettes- (IPC)

113 Projects, page 1 of 23

ALTER-GREF: Randomized prospective phase II clinical trial using post-transplantation cyclophosphamide for prevention of GVHD in haploidentical and HLA 9/10 mismatched unrelated donors hematopoietic stem cell transplant

BACAP Project

Randomized phase III study of gemcitabine and cisplatin (GC) versus high-dose-intensity methotrexate, vinblastine, doxorubicin and cisplatin (HD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder

EPIC-2015: Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers, treated with first-line chemotherapy: a randomized phase III trial

PHOCEA - institut Paoli calmettes Hospital Organization and scientifiC program for Early phase trials Activity

Loading